HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,916,265 | -25.1% | 50,164 | -29.2% | 0.01% | -27.3% |
| Q2 2023 | $2,557,147 | -20.5% | 70,894 | -15.8% | 0.01% | -21.4% |
| Q1 2023 | $3,216,515 | +41521.6% | 84,224 | -38.0% | 0.01% | -61.1% |
| Q4 2022 | $7,728 | +43.9% | 135,812 | 0.0% | 0.04% | +38.5% |
| Q3 2022 | $5,370 | -99.9% | 135,812 | +7.8% | 0.03% | 0.0% |
| Q2 2022 | $5,544,000 | +110.6% | 126,009 | +90.9% | 0.03% | +160.0% |
| Q1 2022 | $2,632,000 | +16.9% | 66,009 | +17.9% | 0.01% | +25.0% |
| Q4 2021 | $2,252,000 | -1.2% | 56,009 | 0.0% | 0.01% | -11.1% |
| Q3 2021 | $2,279,000 | -18.5% | 56,009 | -9.1% | 0.01% | -18.2% |
| Q2 2021 | $2,797,000 | -52.6% | 61,587 | -56.5% | 0.01% | -54.2% |
| Q1 2021 | $5,903,000 | +25.6% | 141,587 | +28.7% | 0.02% | +20.0% |
| Q4 2020 | $4,698,000 | – | 110,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |